These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39241518)

  • 1. In silico design of a novel hybrid epitope-based antigen harboring highly exposed immunogenic peptides of BamA, OmpA, and Omp34 against Acinetobacter baumannii.
    Hessami A; Mogharari Z; Rahim F; Khalesi B; Jamal Nassrullah O; Reza Rahbar M; Khalili S; Jahangiri A
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113066. PubMed ID: 39241518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Highly conserved exposed immunogenic peptides of Omp34 against Acinetobacter baumannii: An innovative approach.
    Jahangiri A; Rasooli I; Owlia P; Imani Fooladi AA; Salimian J
    J Microbiol Methods; 2018 Jan; 144():79-85. PubMed ID: 29133159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.
    Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J
    Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific egg yolk immunoglobulin as a promising non-antibiotic biotherapeutic product against Acinetobacter baumannii pneumonia infection.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Aghajani Z; Abdollahi S; Khalili S; Talei D; Eslam ED
    Sci Rep; 2021 Jan; 11(1):1914. PubMed ID: 33479293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hybrid Antigens Expressing Surface Loops of ZnuD From
    Qamsari MM; Rasooli I; Chaudhuri S; Astaneh SDA; Schryvers AB
    Front Immunol; 2020; 11():158. PubMed ID: 32117294
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluationof the New Outer Membrane Protein A Epitope-based Vaccines for Mice Model of Acinetobacter baumannii Associated Pneumonia and Sepsis Infection.
    Mehdinejadiani K; Hashemi A; Bandehpour M; Rahmani H; Ranjbar MM; Yardel V; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2021 Sep; 20(5):537-549. PubMed ID: 34664813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combating tigecycline resistant Acinetobacter baumannii: A leap forward towards multi-epitope based vaccine discovery.
    Ahmad S; Ranaghan KE; Azam SS
    Eur J Pharm Sci; 2019 Apr; 132():1-17. PubMed ID: 30797936
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Lau YT; Tan HS
    Crit Rev Microbiol; 2024 Aug; 50(4):434-449. PubMed ID: 37211625
    [No Abstract]   [Full Text] [Related]  

  • 9. In Silico Design and Evaluation of Acinetobacter baumannii Outer Membrane Protein a Antigenic Peptides As Vaccine Candidate in Immunized Mice.
    Mehdinejadiani K; Bandehpour M; Hashemi A; Ranjbar MM; Taheri S; Jalali SA; Mosaffa N
    Iran J Allergy Asthma Immunol; 2019 Nov; 18(6):655-663. PubMed ID: 32245309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BauA and Omp34 surface loops trigger protective antibodies against Acinetobacter baumannii in a murine sepsis model.
    Akbari Z; Rasooli I; Ghaini MH; Chaudhuri S; Farshchi Andisi V; Jahangiri A; Ramezanalizadeh F; Schryvers AB
    Int Immunopharmacol; 2022 Jul; 108():108731. PubMed ID: 35367743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity and immunotherapeutic potential of BamA recombinant protein from Acinetobacter baumannii.
    Vieira de Araujo AE; Conde LV; da Silva Junior HC; de Almeida Machado L; Lara FA; Chapeaurouge A; Pauer H; Pires Hardoim CC; Martha Antunes LC; D'Alincourt Carvalho-Assef AP; Moreno Senna JP
    Microbes Infect; 2021; 23(4-5):104801. PubMed ID: 33582283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific egg yolk antibodies (IgY) confer protection against Acinetobacter baumannii in a murine pneumonia model.
    Jahangiri A; Owlia P; Rasooli I; Salimian J; Derakhshanifar E; Naghipour Erami A; Darzi Eslam E; Darvish Alipour Astaneh S
    J Appl Microbiol; 2019 Feb; 126(2):624-632. PubMed ID: 30353977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physicochemical and structural characterization, epitope mapping and vaccine potential investigation of a new protein containing Tetratrico Peptide Repeats of Acinetobacter baumannii: An in-silico and in-vivo approach.
    Abdollahi S; Raoufi Z; Fakoor MH
    Mol Immunol; 2021 Dec; 140():22-34. PubMed ID: 34649027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel approach of virulome based reverse vaccinology for exploring and validating peptide-based vaccine candidates against the most troublesome nosocomial pathogen: Acinetobacter baumannii.
    Ahmad S; Azam SS
    J Mol Graph Model; 2018 Aug; 83():1-11. PubMed ID: 29753164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization with purified OmpA elicited protective immunity against infections caused by multidrug-resistant Acinetobacter baumannii.
    Zhang X; Yang T; Cao J; Sun J; Dai W; Zhang L
    Microb Pathog; 2016 Jul; 96():20-5. PubMed ID: 27133268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of loop 3 of Omp34 from A. Baumannii in loopless C-lobe of TbpB of N. meningitidis.
    Golestani F; Malekan M; Rasooli I; Jahangiri A; Ramezanalizadeh F; Chaudhuri S; Farshchi Andisi V; Schryvers AB
    Int Immunopharmacol; 2022 Sep; 110():109013. PubMed ID: 35785727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoprotective potential of BamA, the outer membrane protein assembly factor, against MDR Acinetobacter baumannii.
    Singh R; Capalash N; Sharma P
    Sci Rep; 2017 Sep; 7(1):12411. PubMed ID: 28963492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of BauA and OmpA elicit immunoprotection against Acinetobacter baumannii in a murine sepsis model.
    Tamehri M; Rasooli I; Pishgahi M; Jahangiri A; Ramezanalizadeh F; Banisaeed Langroodi SR
    Microb Pathog; 2022 Dec; 173(Pt A):105874. PubMed ID: 36356792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First steps towards a vaccine against Acinetobacter baumannii.
    Garcia-Quintanilla M; Pulido MR; McConnell MJ
    Curr Pharm Biotechnol; 2013; 14(10):897-902. PubMed ID: 24372252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico structural and physicochemical characterization of TonB-dependent copper receptor in A. baumannii.
    Abdollahi S; Rasooli I; Mousavi Gargari SL
    Microb Pathog; 2018 May; 118():18-31. PubMed ID: 29524546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.